Beijing Science Sun Pharmaceutical Co., Ltd. (SHE:300485)
China flag China · Delayed Price · Currency is CNY
11.07
+0.03 (0.27%)
Feb 4, 2026, 3:04 PM CST

SHE:300485 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20
Cash & Equivalents
90.8175.26120.16226.21161.54672.53
Trading Asset Securities
1,5641,4961,053895.391,135507.69
Cash & Short-Term Investments
1,6551,5721,1741,1221,2961,180
Cash Growth
8.23%33.92%4.63%-13.47%9.82%-7.68%
Accounts Receivable
47.850.7552.4284.7696.19129.17
Other Receivables
0.991.434.014.080.980.95
Receivables
48.7952.1956.4388.8497.17130.12
Inventory
72.781.37107.0689.09123.05158.64
Other Current Assets
3.766.4715.9920.9113.8314.52
Total Current Assets
1,7801,7121,3531,3201,5301,484
Property, Plant & Equipment
474.5506.68539.42572.18598.9619.7
Long-Term Investments
944.94957.881,4351,3991,012635.23
Goodwill
21.8721.8721.8721.8721.8721.87
Other Intangible Assets
44.1647.1249.9553.7858.4461.21
Long-Term Deferred Tax Assets
1.891.792.425.332.522.77
Long-Term Deferred Charges
336.23292.71208.97184.07158.55146.95
Other Long-Term Assets
0.7312.1611.7912.1219.0119.83
Total Assets
3,6053,5523,6223,5693,4022,991
Accounts Payable
13.8715.7215.1321.6127.4228.24
Accrued Expenses
4.2639.2815.5931.3733.9174.12
Current Income Taxes Payable
4.786.59-0.050.10.01
Current Unearned Revenue
5.645.36.439.1212.5711.1
Other Current Liabilities
33.1415.1614.2912.7914.4522.23
Total Current Liabilities
81.6882.0551.4574.9488.46135.7
Long-Term Unearned Revenue
1.441.24----
Long-Term Deferred Tax Liabilities
88.1483.18103.1682.1630.085.42
Total Liabilities
171.26166.48154.61157.1118.54141.13
Common Stock
481.67481.67481.67481.67481.67481.67
Additional Paid-In Capital
845.93828.2828.2845.93843.56838.32
Retained Earnings
2,0802,0282,1082,0461,9221,486
Comprehensive Income & Other
1.0219.1918.650.33-2.62-1.87
Total Common Equity
3,4093,3573,4363,3743,2452,804
Minority Interest
24.9528.2631.5838.0938.3745.51
Shareholders' Equity
3,4333,3853,4683,4123,2832,850
Total Liabilities & Equity
3,6053,5523,6223,5693,4022,991
Net Cash (Debt)
1,6351,5721,1741,1221,2961,180
Net Cash Growth
6.92%33.92%4.63%-13.47%9.82%-7.68%
Net Cash Per Share
3.433.202.392.362.712.44
Filing Date Shares Outstanding
481.67481.67481.67481.67481.67481.67
Total Common Shares Outstanding
481.67481.67481.67481.67481.67481.67
Working Capital
1,6991,6301,3021,2461,4421,348
Book Value Per Share
7.086.977.137.006.745.82
Tangible Book Value
3,3433,2883,3643,2983,1642,721
Tangible Book Value Per Share
6.946.836.986.856.575.65
Buildings
-511.46511.46510.1451.73455.93
Machinery
-273.02271.91266.38253.18243.86
Construction In Progress
-11.031.050.3371.0658.3
Source: S&P Global Market Intelligence. Standard template. Financial Sources.